The startup develops breath analysis diagnostic systems that utilize biomarker analytical technology and data analysis algorithms to detect health conditions, including breast cancer, through breath signal patterns. This technology enhances the sensitivity and accuracy of point-of-care diagnostics, enabling physicians to improve disease management.
Funding
Funding not disclosed
Founders
Product
Problem
Current breast cancer screening methods, such as mammography, can be uncomfortable, costly, and associated with radiation exposure, leading to infrequent screening and late-stage diagnoses. A significant percentage of breast cancer cases are diagnosed at stage 3 or later, reducing treatment effectiveness and increasing mortality rates. Existing methods may also produce false positives, leading to unnecessary biopsies and increased healthcare costs.
Solution
Maggie's Breath offers a non-invasive breast cancer screening system using breath analysis to detect volatile organic compound (VOC) biomarkers associated with the disease. The BreathSense 1000 system analyzes a patient's exhaled breath using a desktop analytical instrument and disposable breath capture device. Patented technology identifies VOCs with sensitivity as low as 1 part per billion (ppb), providing rapid results at the point of care. This approach aims to provide a more accessible, affordable, and comfortable screening option compared to traditional methods, facilitating earlier detection and improved patient outcomes.
Target Audience
The primary target audience includes women undergoing breast cancer screening, healthcare providers seeking non-invasive diagnostic tools, and hospitals aiming to improve early detection rates.
Features
- Non-invasive breath analysis for breast cancer screening
- BreathSense 1000 desktop analytical instrument
- Disposable breath capture device for sample collection
- Patented technology for VOC biomarker detection with sensitivity down to 1 ppb
- Rapid results at the point of care
- Demonstrated 80% sensitivity in clinical trials for breast cancer detection
- Potential for expansion to detect other cancers through VOC analysis